Back
Black Diamond Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
63
BDTX
Black Diamond Therapeutics
Last Price:
$2.92
Seasonality Move:
-28.39%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BDTX is experiencing slight buying pressure.
Black Diamond Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.74 | Buy |
| 20-day SMA: | 2.68 | Buy |
| 50-day SMA: | 2.68 | Buy |
| 200-day SMA: | 2.28 | Buy |
| 8-day EMA: | 2.73 | Buy |
| 20-day EMA: | 2.71 | Buy |
| 50-day EMA: | 2.62 | Buy |
| 200-day EMA: | 2.64 | Buy |
Black Diamond Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 57.52 | Buy |
| Chaikin Money Flow: | 284847 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.53 - 3.01) | Buy |
| Bollinger Bands (100): | (1.71 - 2.79) | Buy |
Black Diamond Therapeutics Technical Analysis
| Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 18 | Aug 19 | Aug 20 | Aug 21 | Aug 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Black Diamond Therapeutics Stock
Is Black Diamond Therapeutics Stock a Buy?
-
Black Diamond Therapeutics share price is 2.92 while BDTX 8-day simple moving average is 2.74, which is a Buy signal.
-
The stock price of BDTX is 2.92 while Black Diamond Therapeutics 20-day SMA is 2.68, which makes it a Buy.
-
Black Diamond Therapeutics 50-day simple moving average is 2.68 while BDTX share price is 2.92, making it a Buy technically.
-
BDTX stock price is 2.92 and Black Diamond Therapeutics 200-day simple moving average is 2.28, creating a Buy signal.
BDTX Technical Analysis vs Fundamental Analysis
Buy
63
Black Diamond Therapeutics (BDTX)
is a Buy
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a BuyThe current Black Diamond Therapeutics [BDTX] share price is $2.92. The Score for BDTX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Black Diamond Therapeutics Stock Info
Market Cap:
166.3M
Price in USD:
2.92
Share Volume:
1.5M
Black Diamond Therapeutics 52-Week Range
52-Week High:
6.66
52-Week Low:
1.20
Buy
63
Black Diamond Therapeutics (BDTX)
is a Buy
Black Diamond Therapeutics Share Price Forecast
-
What is the Black Diamond Therapeutics stock price today?The Black Diamond Therapeutics stock price is 2.92 USD today.
-
Will BDTX stock go up or go down?Black Diamond Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Black Diamond Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Black Diamond Therapeutics is not overvalued.
Is Black Diamond Therapeutics Stock a Buy?
-
Black Diamond Therapeutics share price is 2.92 while BDTX 8-day exponential moving average is 2.73, which is a Buy signal.
-
The stock price of BDTX is 2.92 while Black Diamond Therapeutics 20-day EMA is 2.71, which makes it a Buy.
-
Black Diamond Therapeutics 50-day exponential moving average is 2.62 while BDTX share price is 2.92, making it a Buy technically.
-
BDTX stock price is 2.92 and Black Diamond Therapeutics 200-day simple moving average is 2.64, creating a Buy signal.
Fundamental Analysis of Black Diamond Therapeutics
Is Black Diamond Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.03 per share, an increase this year of $1.62 per share, and a decrease next year of $1.09 per share.
Technical Analysis of Black Diamond Therapeutics
Should I short Black Diamond Therapeutics stock?
-
BDTX Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Black Diamond Therapeutics is a Buy
-
Black Diamond Therapeutics Relative Strength Index (RSI) is 57.52, which suggest Black Diamond Therapeutics is overbought
-
The Bollinger Bands (25) for Black Diamond Therapeutics is (2.53 - 3.01), which suggest Black Diamond Therapeutics is a Buy
-
The Bollinger Bands (100) for Black Diamond Therapeutics is (1.71 - 2.79), which suggest Black Diamond Therapeutics is a Buy
* Black Diamond Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.